Two articles in the July 25 edition of the New England Journal of Medicine analyze the efficacy of a novel drug for pulmonary arterial hypertension (PAH).
Two articles in the July 25 edition of the New England Journal of Medicine analyze the efficacy of a novel drug for pulmonary arterial hypertension (PAH).